These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30013815)

  • 21. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.
    McElroy SL; Hudson JI; Capece JA; Beyers K; Fisher AC; Rosenthal NR;
    Biol Psychiatry; 2007 May; 61(9):1039-48. PubMed ID: 17258690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity.
    Kotwal R; Guerdjikova A; McElroy SL; Keck PE
    Hum Psychopharmacol; 2006 Oct; 21(7):425-31. PubMed ID: 16941522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phentermine and topiramate extended-release for the obesity: new kids on the block.
    Katsi V; Marketou M; Kallistratos MS; Tousoulis D; Makris T; Manolis AJ; Vardas P; Kallikazaros I
    Recent Pat Cardiovasc Drug Discov; 2013 Apr; 8(1):35-41. PubMed ID: 23565717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?
    Kolotkin RL; Gadde KM; Peterson CA; Crosby RD
    Qual Life Res; 2016 May; 25(5):1237-44. PubMed ID: 26446094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
    McElroy SL; Kotwal R; Guerdjikova AI; Welge JA; Nelson EB; Lake KA; D'Alessio DA; Keck PE; Hudson JI
    J Clin Psychiatry; 2006 Dec; 67(12):1897-906. PubMed ID: 17194267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination phentermine and topiramate for weight maintenance: the first Australian experience.
    Neoh SL; Sumithran P; Haywood CJ; Houlihan CA; Lee FT; Proietto J
    Med J Aust; 2014 Aug; 201(4):224-6. PubMed ID: 25164851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
    Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
    JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phentermine/Topiramate: Pediatric First Approval.
    Dhillon S
    Paediatr Drugs; 2022 Nov; 24(6):715-720. PubMed ID: 36059008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release.
    Guo F; Garvey WT
    Diabetes Care; 2017 Jul; 40(7):856-862. PubMed ID: 28455281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.
    McElroy SL; Guerdjikova A; Kotwal R; Welge JA; Nelson EB; Lake KA; Keck PE; Hudson JI
    J Clin Psychiatry; 2007 Mar; 68(3):390-8. PubMed ID: 17388708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults.
    Aronne LJ; Wadden TA; Peterson C; Winslow D; Odeh S; Gadde KM
    Obesity (Silver Spring); 2013 Nov; 21(11):2163-71. PubMed ID: 24136928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of obesity and cardiometabolic risk - role of phentermine/extended release topiramate.
    Sweeting AN; Tabet E; Caterson ID; Markovic TP
    Diabetes Metab Syndr Obes; 2014; 7():35-44. PubMed ID: 24550678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy.
    Acosta A; Camilleri M; Shin A; Vazquez-Roque MI; Iturrino J; Burton D; O'Neill J; Eckert D; Zinsmeister AR
    Gastroenterology; 2015 Mar; 148(3):537-546.e4. PubMed ID: 25486131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New obesity agents: lorcaserin and phentermine/topiramate.
    Fleming JW; McClendon KS; Riche DM
    Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy.
    Devlin MJ; Goldfein JA; Carino JS; Wolk SL
    Int J Eat Disord; 2000 Nov; 28(3):325-32. PubMed ID: 10942919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of venlafaxine and phentermine/topiramate induced psychosis: A case report.
    Homola J; Hieber R
    Ment Health Clin; 2018 Mar; 8(2):95-99. PubMed ID: 29955552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgery.
    Guerdjikova AI; Kotwal R; McElroy SL
    Obes Surg; 2005 Feb; 15(2):273-7. PubMed ID: 15802073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate for binge-eating disorder associated with obesity.
    Tata AL; Kockler DR
    Ann Pharmacother; 2006 Nov; 40(11):1993-7. PubMed ID: 17047134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phentermine and topiramate extended release (Qsymia™): first global approval.
    Cameron F; Whiteside G; McKeage K
    Drugs; 2012 Oct; 72(15):2033-42. PubMed ID: 23039320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.